- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/76 - Oxygen atoms attached in position 2 or 6
Patent holdings for IPC class C07D 211/76
Total number of patents in this class: 259
10-year publication summary
|
26
|
24
|
25
|
15
|
21
|
21
|
21
|
16
|
15
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4074 |
20 |
| California Institute of Technology | 3976 |
8 |
| Bristol-myers Squibb Company | 4898 |
7 |
| Codexis, Inc. | 801 |
7 |
| The Scripps Research Institute | 1346 |
7 |
| Arvinas Operations, Inc. | 229 |
7 |
| Takeda Pharmaceutical Company Limited | 2713 |
6 |
| BASF SE | 20933 |
5 |
| Daikin Industries, Ltd. | 9995 |
4 |
| Institut Univ. de Ciencia i Tecnologia, S.A. | 22 |
4 |
| InterMune, Inc. | 56 |
4 |
| Queen's University at Kingston | 535 |
4 |
| Merck Patent GmbH | 5831 |
3 |
| Abbott Laboratories | 2399 |
3 |
| ChemoCentryx, Inc. | 385 |
3 |
| Cocrystal Pharma, Inc. | 46 |
3 |
| Dart NeuroScience, LLC | 49 |
3 |
| Emory University | 1626 |
3 |
| Tetraphase Pharmaceuticals, Inc. | 51 |
3 |
| Apexian Pharmaceuticals, Inc. | 3 |
3 |
| Other owners | 152 |